Literature DB >> 18357791

[Lipid peroxidation and antioxidant defence enzyme activity in multiple sclerosis].

E P Pasichna, R P Morozova, H V Donchenko, S M Vinychuk, O O Kopchak.   

Abstract

Changes of state of lipid peroxidation and activity of antioxidant defence enzymes katalase, superoxide dismutase, glutathione peroxidase and glutathione reductase - in the brain and liver tissue of guinea-pig in conditions of different stages of experimental autoimmune encephalomyelitis (EAE; 11th, 21st, 27th day after inoculation) and in blood of multiple sclerosis (MS) patients with different types, degrees of severity and length of disease and blood level of reduced glutathione have been investigated. We have found, that the development of oxidative stress in animal organism during the disease development is progressive and intensive lipid peroxide oxidation without compensation by antioxidant mechanisms have been shown in the late period (27th day) of the experiment. In MS conditions this state was accompanied with high activity of demyelination process, severe degree of neuronal injury and length of disease above 5 years. In addition reduced glutathione level was increased in many patient groups: remitting type, light (II) degree of severity and among the patients with strongly disturbed neurological functions and long course of the disease. The obtained data allow us to suppose that the development of oxidative stress under demyelination conditions is a result of strong metabolic disorders and decrease of antioxidant defence in the patients during the disease development. The necessity of individual approaches for antioxidant therapy of patients with MS is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18357791

Source DB:  PubMed          Journal:  Ukr Biokhim Zh (1999)


  3 in total

Review 1.  Oxidative Stress and Neurobiology of Demyelination.

Authors:  Srdjan Ljubisavljevic
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

2.  IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.

Authors:  Rebecca A Sosa; Cathi Murphey; Rachel R Robinson; Thomas G Forsthuber
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

3.  Redox processes in neurodegenerative disease involving reactive oxygen species.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.